Back
Drug Target Discovery through Somatic Genomics
Thursday, January 28, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Multi-Omics Stage
Day 2 - Thursday 28th January
AI in Drug Discovery
Drug Discovery
Multi-Omics
Information
Somatic mutations in human tissues reveal signals of selection that can uncover disease-driving and disease-protective biology.
Quotient Therapeutics’ platform combines spatial phenotyping, ultra-sensitive sequencing, and computational analysis to identify novel genetically-validated drug targets directly from patient tissues.
Functional validation and drug discovery platforms are advancing those insights toward new therapeutic opportunities.
Speakers
Tim Butler
Principal Scientist
Quotient Therapeutics